Notation to File

NOTE TO THE FILE

SERIAL NUMBER:            88371925

DATE:                                07/08/2019

NAME:                               bdawe

NOTE:         

Searched:                                                             
     Google                            
     Lexis/Nexis                       
     OneLook
     Wikipedia
     Acronym Finder                         Protest evidence reviewed
     Other:

Checked:                                                             
     Geographic significance          
     Surname                          
     Translation
     ID with ID/CLASS mailbox

     Checked list of approved Canadian attorneys and agents

Discussed file with
Attorney/Applicant via:
        phone                               Left message with
        email                               Attorney/Applicant

     Requested Law Library search           Issued Examiner’s Amendment
     for:                                   and entered changes in TRADEUPS

        PRINT        DO NOT PRINT           Added design code in TRADEUPS
     Description of the mark
     Translation statement                  Re-imaged standard character
                                            drawing
     Negative translation statement             
     Consent of living individual           Contacted TM MADRID ID/CLASS
                                            about misclassified definite ID
     Changed TRADEUPS to:

 X    OTHER:

Dear Examining Attorney Dawe,

 

We write further to your June 14, 2019 Office Action in connection with the above-referenced application.

 

The Applicant agrees to amend the identification as follows:

 

Pharmaceutical and medicated preparations, namely, for use in nephrology, neurology, oncology, urology, andrology and cardiology, and for use in the treatment of nasal allergies, respiratory allergies, and for use as anti-infectives; contraceptive preparations; dietary and nutritional supplements; prenatal vitamins; pharmaceutical products for the treatment of bone diseases; preparations for the suppression of hormones; pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of overactive bladder, female sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis/osteopenia, pelvic pain, dyspareunia, and candidiasis; all of the aforesaid goods not for use as a product name of a pharmaceutical product, in International Class 5

 

Further, Applicant agrees to enter the following disclaimer into the record:

 

No claim is made to the exclusive right to use “PHARMACEUTICALS” apart from the mark as shown. 

 

Finally, “SEBELA” is a coined term, and is not a surname or a given name.

 

“SEBELA” has no meaning or significance in the industry in which the goods are manufactured, is not a “term of art” within applicant’s industry, nor any geographical significance.

 

The wording “SEBELA” has no meaning in a foreign language.

 

You are hereby authorized to issue an Examiner’s Amendment in this regard.

 

We look forward to hearing from you, and appreciate your time and attention to this matter.

 

Best Regards,

Jeff

 

Jeffrey H. Handelsman

Greenblum & Bernstein, P.L.C.
1950 Roland Clarke Place
Reston, VA  20191
USA